Your session is about to expire
← Back to Search
Motor-based Intervention for Childhood Apraxia of Speech
N/A
Recruiting
Led By Maria I Grigos, PhD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of childhood apraxia of speech (CAS) based on specific criteria including the presence of inconsistent consonant and vowel errors, difficulties forming accurate movement between sounds and syllables, and prosodic errors, as well as demonstration of at least four additional characteristics
Age between 2.5 and 7.11 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through the treatment phase (32 treatment sessions over 8 weeks)
Awards & highlights
Study Summary
This trial is testing a new treatment, Dynamic Temporal and Tactile Cuing (DTTC), to see if it helps children with Childhood Apraxia of Speech (CAS). CAS is a speech motor disorder where children have difficulty planning and programming movements of the speech articulators. The goal is to see if DTTC improves speech production in children with CAS, by looking at the impact of DTTC on treated words, generalization to untreated words and post-treatment maintenance.
Who is the study for?
This trial is for children aged 2.5 to almost 8 years with Childhood Apraxia of Speech (CAS) who have never had DTTC treatment, can pass a hearing test, and show specific speech difficulties without other neurological or developmental disorders.Check my eligibility
What is being tested?
The study tests the effectiveness of Dynamic Temporal and Tactile Cuing (DTTC), a motor-based speech therapy, on improving word production in kids with CAS. It looks at how well they learn treated words, if it helps with untreated words, and if improvements last after treatment ends.See study design
What are the potential side effects?
Since this intervention involves speech therapy techniques rather than medication, traditional side effects are not expected. However, there may be varying levels of fatigue or frustration during the learning process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child has been diagnosed with CAS, showing specific speech difficulties.
Select...
I am between 2.5 and 8 years old.
Select...
I have never received DTTC treatment.
Select...
My mouth and throat structures are normal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through the treatment phase (32 treatment sessions over 8 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through the treatment phase (32 treatment sessions over 8 weeks)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in word accuracy
Secondary outcome measures
Changes in the duration of segments and words
Changes in the percentage of words correctly identified by a listener
Changes in the speech motor variability of segments and words
Trial Design
2Treatment groups
Experimental Treatment
Group I: Immediate TreatmentExperimental Treatment1 Intervention
Participants in the Immediate Treatment Group will receive DTTC Treatment four times per week (45-minute sessions each) for 8 weeks. Total duration will be 180 minutes/week over 32 sessions. Treatment will begin between 1-3 weeks following the diagnostic evaluation.
Group II: Delayed TreatmentExperimental Treatment1 Intervention
The Delayed Treatment Group serves as a control during the period in which participants are waiting to begin treatment. A delayed treatment onset is employed to control for maturation effects. Participants in the Delayed Treatment Group will receive DTTC Treatment four times per week (45-minute sessions each) for 8 weeks. Total duration will be 180 minutes/week over 32 sessions. Treatment will begin after an 8-week delay following the diagnostic evaluation.
Find a Location
Who is running the clinical trial?
New York UniversityLead Sponsor
226 Previous Clinical Trials
314,045 Total Patients Enrolled
2 Trials studying Childhood Apraxia of Speech
100 Patients Enrolled for Childhood Apraxia of Speech
Maria I Grigos, PhDPrincipal InvestigatorNew York University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child has a speech fluency disorder, even though they have been diagnosed with CAS.I have been treated with DTTC before.I have hearing loss, even though I also have CAS.My child has been diagnosed with CAS, showing specific speech difficulties.I am between 2.5 and 8 years old.You have difficulty speaking clearly, even if you meet the criteria for childhood apraxia of speech.I have never received DTTC treatment.You can hear well during a hearing test at different pitches and volumes.I have a neurological, developmental, or genetic disorder.My mouth and throat structures are normal.
Research Study Groups:
This trial has the following groups:- Group 1: Immediate Treatment
- Group 2: Delayed Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the qualifications of ideal participants in this research?
"To be accepted into this trial, individuals should display symptoms of apraxia and fall between 30 months to 60 months in age. The research team is currently planning on recruiting 72 patients."
Answered by AI
Are there vacancies available for individuals who want to join this trial?
"Clinicaltrials.gov indicates that this research study, initially announced on September 14th 2021 is currently recruiting participants. The latest update was made October 31st 2022."
Answered by AI
Are the requirements for this test exclusive to those over a quarter century of age?
"Compliance with the enrollment requirements necessitates that all participants are aged between 2.5 years and 5 years old."
Answered by AI
How many participants are currently enrolled in this clinical research project?
"Affirmative. Clinicaltrials.gov's records divulge that this medical study, which was first posted on September 14th 2021, is currently seeking participants. 72 patients must be enrolled from 1 clinical location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger